001     867642
005     20210130003826.0
024 7 _ |a 10.1007/s10562-019-03015-y
|2 doi
024 7 _ |a 1011-372X
|2 ISSN
024 7 _ |a 1572-879X
|2 ISSN
024 7 _ |a 2128/24950
|2 Handle
024 7 _ |a WOS:000495029200001
|2 WOS
037 _ _ |a FZJ-2019-06263
082 _ _ |a 660
100 1 _ |a Contente, Martina Letizia
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Stereoselective Reduction of Prochiral Cyclic 1,3-Diketones Using Different Biocatalysts
260 _ _ |a Dordrecht [u.a.]
|c 2020
|b Springer Science + Business Media B.V
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1591712552_25233
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a We have developed biocatalytic methods for the stereoselective reduction of cyclic prochiral 1,3-diketones for the production of optically active β-hydroxyketones and/or 1,3-diols. The recombinant ketoreductase KRED1-Pglu (formulated as purified catalyst) and whole cells of wild type Escherichia coli DE3 Star were used as biocatalysts, displaying different and sometimes complementary stereoselectivity, thus allowing the preparation of stereochemically pure β-hydroxyketones (12–66% isolated yields, > 99% e.e.) and 1,3-diols (40–60% isolated yields, > 99% e.e.).
536 _ _ |a 581 - Biotechnology (POF3-581)
|0 G:(DE-HGF)POF3-581
|c POF3-581
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Dall’Oglio, Federica
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Annunziata, Francesca
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Molinari, Francesco
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Rabuffetti, Marco
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Romano, Diego
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Tamborini, Lucia
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Rother, Dörte
|0 P:(DE-Juel1)144643
|b 7
|u fzj
700 1 _ |a Pinto, Andrea
|0 P:(DE-HGF)0
|b 8
|e Corresponding author
773 _ _ |a 10.1007/s10562-019-03015-y
|0 PERI:(DE-600)1501518-x
|p 1176-1185
|t Catalysis letters
|v 150
|y 2020
|x 1572-879X
856 4 _ |u https://juser.fz-juelich.de/record/867642/files/Contente2020_Article_StereoselectiveReductionOfProc-1.pdf
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/867642/files/Contente%20et%20al%20manuscript%20catalysis%20letters_revised_clean%20copy.pdf
|y Published on 2019-11-07. Available in OpenAccess from 2020-11-07.
|z StatID:(DE-HGF)0510
856 4 _ |u https://juser.fz-juelich.de/record/867642/files/Contente2020_Article_StereoselectiveReductionOfProc-1.pdf?subformat=pdfa
|x pdfa
|y Restricted
909 C O |o oai:juser.fz-juelich.de:867642
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 7
|6 P:(DE-Juel1)144643
913 1 _ |a DE-HGF
|b Key Technologies
|l Key Technologies for the Bioeconomy
|1 G:(DE-HGF)POF3-580
|0 G:(DE-HGF)POF3-581
|2 G:(DE-HGF)POF3-500
|v Biotechnology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2020
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1160
|2 StatID
|b Current Contents - Engineering, Computing and Technology
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Embargoed OpenAccess
|0 StatID:(DE-HGF)0530
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CATAL LETT : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
920 1 _ |0 I:(DE-Juel1)IBG-1-20101118
|k IBG-1
|l Biotechnologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)IBG-1-20101118
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21